Urania Therapeutics
Operator of a biopharmaceutical company intended to treat genetic diseases caused by mutations. The company's compounds induce the overcoming of premature stop codons during protein synthesis to allow...
Valuation
$5.4M
Market implied
Share Price
N/A
Total Raised
$8.1M
Last Round
N/A